Literature DB >> 23145397

Thyroid disease in the perinatal period.

Simon Forehan1.   

Abstract

BACKGROUND: Thyroid hormone plays a critical role in fetal development. In pregnancy, increased thyroid hormone synthesis is required to meet fetal needs, resulting in increased iodine requirements.
OBJECTIVE: This article outlines changes to thyroid physiology and iodine requirements in pregnancy, pregnancy specific reference ranges for thyroid function tests and detection and management of thyroid conditions in pregnancy. DISCUSSION: Thyroid dysfunction affects 2-3% of pregnant women. Pregnancy specific reference ranges are required to define thyroid conditions in pregnancy and to guide treatment. Overt maternal hypothyroidism is associated with adverse pregnancy outcomes; thyroxine treatment should be commenced immediately in this condition. Thyroxine treatment has also been shown to be effective for pregnant women with subclinical hypothyroidism who are thyroid peroxidase antibody positive. Gestational thyrotoxicosis needs to be differentiated from Graves disease and rarely requires thionamide treatment. Postpartum thyroiditis most commonly presents with isolated hypothyroidism but a biphasic presentation and isolated hyperthyroidism can occur: a high index of suspicion is warranted for diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23145397

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  4 in total

1.  Management of thyroid disease in pregnancy - Room for improvement in the first trimester.

Authors:  Helen Robinson; Philip Robinson; Michael D'Emden; Kassam Mahomed
Journal:  Obstet Med       Date:  2016-04-13

2.  Reporting of gestational diabetes and other maternal medical conditions: validation of routinely collected hospital data from New South Wales, Australia.

Authors:  Heather J Baldwin; Tanya A Nippita; Kristen Rickard; Siranda Torvaldsen; Therese M McGee; Jillian A Patterson
Journal:  Int J Popul Data Sci       Date:  2021-02-22

3.  Impact of maternal thyroperoxidase status on fetal body and brain size.

Authors:  Roneé E Wilson; Hamisu M Salihu; Maureen W Groer; Getachew Dagne; Kathleen O'Rourke; Alfred K Mbah
Journal:  J Thyroid Res       Date:  2014-01-29

Review 4.  Nuclear Receptors, Ligands and the Mammalian B Cell.

Authors:  Bart G Jones; Rhiannon R Penkert; Sherri L Surman; Robert E Sealy; Julia L Hurwitz
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.